Prices delayed by at least 15 minutes | Print
Maxcyte INC (MXCT)
COM STK USD0.01 (DI)This share can be held in a Dealing accountISALifetime ISAJISASIPPand can be used with Dividend reinvestment
Company profile
MaxCyte Inc is a commercial cell engineering company focused on providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell therapeutics and to support cell-based research and development. The company has developed and commercialized a proprietary Flow Electroporation platform, which facilitates the complex engineering of a wide variety of cells. The revenue is generated from the sale and licensing of company's instruments, as well as sales of single-use disposable processing assemblies.
Address
22 Firstfield Road
Suite 110
Gaithersburg
MD
USA
20878
Telephone
+1 301 944-1700
Forecast key dates
Name | Key Date |
---|---|
MaxCyte Inc First Quarter Earnings Conference Call for 2025 | 2025-05-07T16:30:00 |
MaxCyte Inc First Quarter Earnings Results for 2025 | 2025-05-07T00:00:00 |
MaxCyte Inc Fourth Quarter Earnings Conference Call for 2024 | 2025-03-12T16:30:00 |
MaxCyte Inc Fourth Quarter Earnings Results for 2024 | 2025-03-12T00:00:00 |
MaxCyte Inc Annual Report for 2024 | 2025-03-12T00:00:00 |
MaxCyte Inc Third Quarter Earnings Conference Call for 2024 | 2024-11-08T16:30:00 |
MaxCyte Inc Third Quarter Earnings Results for 2024 | 2024-11-08T00:00:00 |
MaxCyte Inc Second Quarter Earnings Conference Call for 2024 | 2024-08-09T16:30:00 |
MaxCyte Inc Second Quarter Earnings Results for 2024 | 2024-08-09T00:00:00 |
MaxCyte Inc Annual General Meeting for 2024 | 2024-06-11T11:00:00 |
MaxCyte Inc First Quarter Earnings Conference Call for 2024 | 2024-05-07T16:30:00 |
MaxCyte Inc First Quarter Earnings Result for 2024 | 2024-05-07T00:00:00 |
Previous key dates
Name | Key Date |
---|---|
MaxCyte Inc First Quarter Earnings Conference Call for 2024 | 2024-05-07T16:30:00 |
MaxCyte Inc First Quarter Earnings Result for 2024 | 2024-05-07T00:00:00 |
MaxCyte Inc Fourth Quarter Earnings Conference Call for 2023 | 2024-03-12T16:30:00 |
MaxCyte Inc Fourth Quarter Earnings Result for 2023 | 2024-03-12T00:00:00 |
MaxCyte Inc Annual Report for 2023 | 2024-03-12T00:00:00 |
MaxCyte Inc Third Quarter Earnings Conference Call for 2023 | 2023-11-08T16:30:00 |
MaxCyte Inc Third Quarter Earnings Result for 2023 | 2023-11-08T00:00:00 |
MaxCyte Inc Second Quarter Earnings Conference Call for 2023 | 2023-08-09T16:30:00 |
MaxCyte Inc Second Quarter Earnings Result for 2023 | 2023-08-09T00:00:00 |
MaxCyte Inc Annual General Meeting for 2023 | 2023-06-22T11:00:00 |
MaxCyte Inc First Quarter Earnings Conference Call for 2023 | 2023-05-10T16:30:00 |
MaxCyte Inc First Quarter Earnings Result for 2023 | 2023-05-10T00:00:00 |
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2024 AJ Bell. All rights reserved.